Provenance du réseau au premier degré de Dawn Schottlandt
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dawn Schottlandt via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of New Hampshire | College/University | Undergraduate Degree | |
| STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Corporate Officer/Principal | |
| MediVector, Inc. | General Counsel | ||
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | General Counsel | |
| George Washington University | College/University | Undergraduate Degree | |
| University of Rochester Simon Business School | College/University | Masters Business Admin | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Biotechnology | Corporate Officer/Principal | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal | |
| Ignition Insights LLC | Founder | ||
| Cambridge College | College/University | Graduate Degree | |
| AURA BIOSCIENCES, INC. | Biotechnology | Human Resources Officer |
Statistiques
Internationale
| Etats-Unis | 16 |
| Canada | 2 |
Sectorielle
| Health Technology | 10 |
| Consumer Services | 5 |
| Consumer Non-Durables | 2 |
Opérationnelle
| Corporate Officer/Principal | 9 |
| General Counsel | 3 |
| Undergraduate Degree | 2 |
| Human Resources Officer | 2 |
| Masters Business Admin | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Anand Varadan | 9 |
| David H. Schubert | 7 |
| Joseph Lyons | 3 |
- Bourse
- Insiders
- Dawn Schottlandt
- Connexions Sociétés
